EUVIMEDEUVIMED entdecken
Crossref

CO160 DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS

Da Sol Kim, Beverly Fuerte, Chanhyun Park

Value in Health · 2026-06 · 29 (6) · S53

DOI: 10.1016/j.jval.2026.03.255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Da Sol Kim und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kim, D. S., Fuerte, B., & Park, C. (2026). CO160 DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS. Value in Health, 29(6), S53. https://doi.org/10.1016/j.jval.2026.03.255

Vancouver

Kim DS, Fuerte B, Park C. CO160 DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS. Value in Health. 2026;29(6):S53. doi:10.1016/j.jval.2026.03.255

BibTeX
@article{Kim2026,
  author = {Kim, Da Sol and Fuerte, Beverly and Park, Chanhyun},
  title = {CO160 DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S53},
  doi = {10.1016/j.jval.2026.03.255}
}
Kostenlos starten →